Victoria Mira (née Jenkins)

Victoria Mira (née Jenkins) has an extensive work experience in the field of pharmaceuticals and vaccine development. Victoria is currently working at Bavarian Nordic as the Senior Director and Chikungunya Vaccine Development Lead. In this role, they lead the development organization for the recently acquired chikungunya vaccine, with direct reports from various departments such as RA, Clin Ops, Clin strategy, Bio stats, and Data management. Additionally, they serve as the overall program lead, responsible for successfully completing the Phase 3 studies, filing, manufacturing, and launching the vaccine.

Prior to their current position, Victoria worked at GSK where they held the role of Senior Manager and Manager in Global Medical Affairs Vaccines. Victoria also completed the Future Leaders Programme (FLP) in R&D during their time at GSK.

Before joining GSK, Victoria worked as a Post-Doctoral Research Associate at the Liverpool School of Tropical Medicine, and prior to that, they served as a Graduate Researcher (PhD) at Imperial College London.

Overall, Victoria Mira has a strong background in vaccine development, clinical strategy, and medical affairs, and they have gained valuable experience in leading teams and programs throughout their career.

Victoria Mira (née Jenkins) has a diverse education history in various fields of study. Victoria holds a Bachelor's degree in Natural Science from the University of Cambridge. Although the exact duration of their study is not specified, it can be assumed that they completed their degree before moving on to pursue higher education.

Victoria then attended the IE Business School, where they obtained a Master of Business Administration (MBA) degree. Again, the specific timeframe for this degree is not provided.

Continuing their academic journey, Victoria enrolled at Imperial College London, where they pursued a Doctor of Philosophy (Ph.D.) in Molecular Microbiology. Unfortunately, the duration of their Ph.D. program is not mentioned.

Additionally, Victoria earned a Master of Science (MSc) degree from Imperial College London, specializing in Molecular Biology and Pathology of Viruses. The specific timeframe for this degree is also not specified.

Finally, Victoria expanded their knowledge and expertise by attending Harvard Medical School, where they completed the HMX pro program. This program focused on Cancer Genomics and Precision Oncology, as well as Immuno-oncology. Unfortunately, the duration of their studies at Harvard is not provided.

In summary, Victoria Mira (née Jenkins) has pursued studies in Natural Science, Business Administration, Molecular Microbiology, Molecular Biology, Pathology of Viruses, and Cancer Genomics. Although the exact timing and order of their degrees are not given, it is evident that they have a diverse educational background spanning multiple institutions.